1-(2-FURYL)-1,3-BUTANEDIONE
General Information
Mainterm | 1-(2-FURYL)-1,3-BUTANEDIONE |
Doc Type | NUL |
CAS Reg.No.(or other ID) | 25790-35-6 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 12168 |
IUPAC Name | 1-(furan-2-yl)butane-1,3-dione |
InChI | InChI=1S/C8H8O3/c1-6(9)5-7(10)8-3-2-4-11-8/h2-4H,5H2,1H3 |
InChI Key | GPYKJDYMMUIUFG-UHFFFAOYSA-N |
Canonical SMILES | CC(=O)CC(=O)C1=CC=CO1 |
Molecular Formula | C8H8O3 |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 152.149 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Complexity | 174.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B w M A A A A A A A A A A A A A A A A A A A A S A A A A A A A A A A A A A A A A A B g A A A G g A A A A A A C A S g k A I y B I A A B E C I A K h S g A I C C A A k I A A I i A F G C M g M J j K M N R 6 C G S C k w B E I q Y e L z q C g A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 47.3 |
Monoisotopic Mass | 152.047 |
Exact Mass | 152.047 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 11 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9934 |
Human Intestinal Absorption | HIA+ | 0.9965 |
Caco-2 Permeability | Caco2+ | 0.5584 |
P-glycoprotein Substrate | Non-substrate | 0.7048 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6453 |
Non-inhibitor | 0.6326 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8877 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7278 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8123 |
CYP450 2D6 Substrate | Non-substrate | 0.8775 |
CYP450 3A4 Substrate | Non-substrate | 0.7558 |
CYP450 1A2 Inhibitor | Inhibitor | 0.5281 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8207 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9451 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6466 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9699 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7878 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9387 |
Non-inhibitor | 0.9711 | |
AMES Toxicity | Non AMES toxic | 0.6862 |
Carcinogens | Non-carcinogens | 0.7047 |
Fish Toxicity | High FHMT | 0.5062 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9954 |
Honey Bee Toxicity | High HBT | 0.5925 |
Biodegradation | Ready biodegradable | 0.8210 |
Acute Oral Toxicity | III | 0.6711 |
Carcinogenicity (Three-class) | Non-required | 0.4233 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.0476 | LogS |
Caco-2 Permeability | 0.9682 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.8488 | LD50, mol/kg |
Fish Toxicity | 0.5313 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.3996 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Carbonyl compounds |
Intermediate Tree Nodes | Ketones - Aryl ketones |
Direct Parent | Aryl alkyl ketones |
Alternative Parents | |
Molecular Framework | Aromatic heteromonocyclic compounds |
Substituents | Aryl alkyl ketone - 1,3-diketone - 1,3-dicarbonyl compound - Heteroaromatic compound - Furan - Oxacycle - Organoheterocyclic compound - Organic oxide - Hydrocarbon derivative - Aromatic heteromonocyclic compound |
Description | This compound belongs to the class of organic compounds known as aryl alkyl ketones. These are ketones have the generic structure RC(=O)R', where R = aryl group and R'=alkyl group. |
From ClassyFire